Internal Medicine, Endocrinology, Diabetes, & Metabolism · Seattle, WA
NPI
1033185137
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
1100 9th Ave
Seattle, WA, 98101
Phone (206) 223-6624
Groups this clinician bills Medicare through
Medicare paid, 2024
$113K
3,839 services
Medicare patients, 2024
241
Average age 73
Drug cost, 2024
$386K
1,671 prescriptions
Company payments, 2025
$124
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Grace A Lee was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 236 times for 113 patients. In total Grace A Lee billed 3,839 services in 22 codes, and Medicare paid $113K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-12-23.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 236 | 113 | $13.32 | $3,143 |
| 99215 Office E&M - Established | Office | 222 | 98 | $148.86 | $33K |
| 36415 Venipuncture Blood Collection | Office | 204 | 97 | $8.65 | $1,765 |
| 99233 Hospital E&M - Subsequent | Facility | 169 | 51 | $99.07 | $17K |
| 99214 Office E&M - Established | Office | 78 | 44 | $97.48 | $7,603 |
| 99215 Office E&M - Established | Facility | 70 | 44 | $119.50 | $8,365 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 70 | 47 | $13.62 | $953 |
| 99222 Hospital E&M - Initial | Facility | 50 | 48 | $109.04 | $5,452 |
| 99232 Hospital E&M - Subsequent | Facility | 43 | 15 | $65.68 | $2,824 |
| 99205 Office E&M - New | Office | 17 | 17 | $177.37 | $3,015 |
| 95251 Test - Miscellaneous | Office | 15 | 11 | $26.64 | $400 |
By year: 2022 $108K for 4,621 services; 2023 $88K for 6,748 services; 2024 $113K for 3,839 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 204 | 97 | $8.65 | $1,765 |
Medicare prescription drug claims, 2024
In 2024, the drug Grace A Lee prescribed most often to Medicare patients was Levothyroxine Sodium, with 372 prescriptions and refills. In total Grace A Lee wrote 1,671 Medicare prescriptions that cost $386K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 372 | 833 | 76 | $5,371 |
| Mounjaro Tirzepatide | 123 | 134 | 20 | $142K |
| Alendronate Sodium Generic | 75 | 185 | 30 | $670 |
| Synthroid Levothyroxine Sodium | 74 | 192 | 16 | $6,691 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 61 | 123 | 18 | $9,422 |
| Metformin Hcl Generic | 48 | 122 | 17 | $423 |
| Methimazole Generic | 42 | 112 | 12 | $346 |
| Jardiance Empagliflozin | 39 | 66 | Under 11 | $38K |
| Humalog Kwikpen U-100 Insulin Lispro | 39 | 84 | 14 | $10K |
| Hydrocortisone Generic | 38 | 95 | 11 | $2,583 |
| Glimepiride Generic | 38 | 83 | Under 11 | $324 |
| Metformin Hcl Er Metformin Hcl | 30 | 88 | 11 | $234 |
| Losartan Potassium Generic | 29 | 77 | Under 11 | $256 |
| Atorvastatin Calcium Generic | 26 | 78 | 11 | $432 |
| Novolog Insulin Aspart | 24 | 51 | Under 11 | $6,232 |
Brand drugs: 716 claims; generic drugs: 855 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Grace A Lee $124 ($124 in general payments such as food, travel and fees) from 1 company. The largest payer was Ascendis Pharma Endocrinology Inc with $124.
| Company | Payments | Amount |
|---|---|---|
| Ascendis Pharma Endocrinology Inc ASND | 1 | $124 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.